A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach

There are currently four anti-cancer medicinal products approved for a tissue-agnostic indication. This is an indication based on a common biological characteristic rather than the tissue of origin. To date, the regulatory experience with tissue-agnostic approvals is limited. Therefore, we compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Jorn, van Stuijvenberg, Odile C., van Hennik, Paula B., Voest, Emile E., Pasmooij, Anna M. G., Stoyanova-Beninska, Violeta, de Boer, Anthonius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237332/
https://www.ncbi.nlm.nih.gov/pubmed/35775007
http://dx.doi.org/10.3389/fmed.2022.893400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237332/
https://www.ncbi.nlm.nih.gov/pubmed/35775007
http://dx.doi.org/10.3389/fmed.2022.893400

Ejemplares similares